These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37672298)

  • 21. Post-Acute COVID 19 Syndrome, 'Long COVID'.
    O'Keefe LC
    Workplace Health Saf; 2023 May; 71(5):263. PubMed ID: 37129095
    [No Abstract]   [Full Text] [Related]  

  • 22. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China.
    Cai J; Lin K; Zhang H; Xue Q; Zhu K; Yuan G; Sun Y; Zhu F; Ai J; Wang S; Zhang W
    Emerg Microbes Infect; 2023 Dec; 12(2):2220578. PubMed ID: 37272336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Review of Neurological Symptoms in Long COVID and Clinical Management.
    Navis A
    Semin Neurol; 2023 Apr; 43(2):286-296. PubMed ID: 37068519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Post-COVID sequela of the lung - follow up and treatment].
    Gogoll C; Leo F; Schueller PO; Grohé C
    Dtsch Med Wochenschr; 2021 Oct; 146(21):1399-1404. PubMed ID: 34670282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating common and potentially modifiable symptoms of post-COVID-19 condition (long COVID) in adults.
    Quinn KL; Cheung AM; Razak F
    CMAJ; 2023 Jan; 195(2):E80-E81. PubMed ID: 36649947
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessing common and potentially modifiable symptoms of post-COVID-19 condition (long COVID) in adults.
    Quinn KL; Razak F; Cheung AM
    CMAJ; 2023 Jan; 195(2):E76-E77. PubMed ID: 36649958
    [No Abstract]   [Full Text] [Related]  

  • 27. Post COVID fatigue: Can we really ignore it?
    Sharma P; Bharti S; Garg I
    Indian J Tuberc; 2022 Apr; 69(2):238-241. PubMed ID: 35379408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low Prevalence of Interferon α Autoantibodies in People Experiencing Symptoms of Post-Coronavirus Disease 2019 (COVID-19) Conditions, or Long COVID.
    Peluso MJ; Mitchell A; Wang CY; Takahashi S; Hoh R; Tai V; Durstenfeld MS; Hsue PY; Kelly JD; Martin JN; Wilson MR; Greenhouse B; Deeks SG; DeRisi JL; Henrich TJ
    J Infect Dis; 2023 Jan; 227(2):246-250. PubMed ID: 36089700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparing for the long-haul: Autonomic complications of COVID-19.
    Larsen NW; Stiles LE; Miglis MG
    Auton Neurosci; 2021 Nov; 235():102841. PubMed ID: 34265539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post COVID syndrome: a new challenge for medicine.
    Tirelli U; Taibi R; Chirumbolo S
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(12):4422-4425. PubMed ID: 34227079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
    Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
    Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long COVID in Children and Young after Infection or Reinfection with the Omicron Variant: A Prospective Observational Study.
    Pinto Pereira SM; Mensah A; Nugawela MD; Stephenson T; Ladhani SN; Dalrymple E; Dudley J; McOwat K; Simmons R; Heyman I; Segal T; Semple MG; Xu L; ; Shafran R
    J Pediatr; 2023 Aug; 259():113463. PubMed ID: 37172813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment.
    Mazza MG; Palladini M; Poletti S; Benedetti F
    CNS Drugs; 2022 Jul; 36(7):681-702. PubMed ID: 35727534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long COVID and older people.
    Mansell V; Hall Dykgraaf S; Kidd M; Goodyear-Smith F
    Lancet Healthy Longev; 2022 Dec; 3(12):e849-e854. PubMed ID: 36480981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long COVID and its Management.
    Koc HC; Xiao J; Liu W; Li Y; Chen G
    Int J Biol Sci; 2022; 18(12):4768-4780. PubMed ID: 35874958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Long-COVID Experience Changed People's Vaccine Hesitancy but Not Their Vaccination Fear.
    Duradoni M; Gursesli MC; Materassi L; Serritella E; Guazzini A
    Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Why the hypothesis of psychological mechanisms in long COVID is worth considering.
    Lemogne C; Gouraud C; Pitron V; Ranque B
    J Psychosom Res; 2023 Feb; 165():111135. PubMed ID: 36623391
    [No Abstract]   [Full Text] [Related]  

  • 38. Long COVID: what is known and what gaps need to be addressed.
    Krishna B; Wills M; Sithole N
    Br Med Bull; 2023 Sep; 147(1):6-19. PubMed ID: 37434326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients.
    Peghin M; Palese A; Venturini M; De Martino M; Gerussi V; Graziano E; Bontempo G; Marrella F; Tommasini A; Fabris M; Curcio F; Isola M; Tascini C
    Clin Microbiol Infect; 2021 Oct; 27(10):1507-1513. PubMed ID: 34111579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long COVID-19 prevalence among a sample of infected people in Erbil city.
    Hawar AS; Dauod AS
    J Popul Ther Clin Pharmacol; 2022; 29(3):e123-e133. PubMed ID: 36196947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.